NEW YORK (GenomeWeb News) — Certain top executives of newly created Thermo Fisher Scientific have adopted a plan to unload millions of shares of the company’s stock, the company said today.
The firm said Chairman Paul Meister plans to sell up to 2.25 million shares and CEO Marijn Dekkers plans to sell just over 1 million shares. The sale would leave Meister with 2.25 million shares and Dekkers with 2.9 million shares or equivalents.
Dekkers would acquire the shares he plans to sell when he exercises a stock option that was granted when he joined Thermo in 2000. The option expires in July 2007.
Thermo Fisher Scientific said the plan by Meister, Dekkers, and other “certain executive officers” is based on Securities and Exchange Commission stock-trading rules.
As GenomeWeb News reported on Nov. 9, Thermo Electron and Fisher Scientific closed their $10.6 billion merger to create Thermo Fisher Scientific.
Dekkers’ and Meister’s shares amount to around 2 percent of the company’s outstanding shares.